ASRAX | CSFZX | ASRAX / CSFZX | |
Total Expense Ratio | 1.26 | 0.84 | 150% |
Annual Report Gross Expense Ratio | 1.26 | 0.84 | 150% |
Fund Existence | 23 years | 11 years | - |
Gain YTD | 5.054 | 8.806 | 57% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 409M | 2.01B | 20% |
Annual Yield % from dividends | 3.30 | 2.89 | 114% |
Returns for 1 year | 3.95 | 9.08 | 43% |
Returns for 3 years | 5.28 | 10.40 | 51% |
Returns for 5 years | 20.57 | 36.16 | 57% |
Returns for 10 years | 23.84 | 48.72 | 49% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GMVCX | 15.79 | 0.14 | +0.89% |
Goldman Sachs Small/Mid Cap Equity C | |||
FCDCX | 31.44 | 0.26 | +0.83% |
Fidelity Advisor Stock Selector Sm Cp C | |||
PHLAX | 33.09 | 0.17 | +0.52% |
PGIM Jennison Health Sciences A | |||
PISVX | 10.07 | 0.01 | +0.10% |
Victory Pioneer Intrinsic Value A | |||
FGIWX | 12.88 | -0.01 | -0.08% |
Nuveen Global Infrastructure R6 |